Pharmaniaga Berhad reported earnings results for the fourth quarter ended December 31, 2022. For the fourth quarter, the company reported sales was MYR 862.72 million compared to MYR 711.72 million a year ago. Net loss was MYR 644.39 million compared to net income of MYR 85.48 million a year ago.

Basic loss per share from continuing operations was MYR 0.4919 compared to basic earnings per share from continuing operations of MYR 0.0653 a year ago. Diluted loss per share from continuing operations was MYR 0.4919 compared to diluted earnings per share from continuing operations of MYR 0.0653 a year ago.